Pentosan in transmissible spongiform encephatopathies [3]

Lancet

Volumn 353, Issue 9160, 1999, Pages 1272-

  Deli, M A ^a   Niwa, M ^a   Katamine, S ^a   Abraham, C S ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; GLYCOSAMINOGLYCAN; PENTOSAN POLYSULFATE; PRION PROTEIN;

BRAIN SPONGIOSIS; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG EFFICACY; ENDOCYTOSIS; GASTROINTESTINAL ABSORPTION; INTRAPERITONEAL DRUG ADMINISTRATION; LETTER; NEUROBLASTOMA CELL; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0033541494     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)66946-2     Document Type: Letter

References (4)

1. C Farquhar A Dickinson M Bruce Prophylactic potential of pentosan polysulphate in transmissible spongiform encephalopathies Lancet 353 1999 117
2. S Dealler Post-exposure prophylaxis after accidental prion inoculation Lancet 351 1998 600
3. c, in cultured cells J Biol Chem 270 1995 30221 30229
4. B Leveugle W Ding F Laurence Heparin oligosaccharides that pass the bloodbrain barrier inhibit β-amyloid peptide J Neurochem 70 1998 736 744